Disposition of 3219 shares by Roop Lakkaraju of Benchmark Electronics at 29.73 subject to Rule 16b-3

BIO Stock  USD 340.53  2.05  0.61%   
About 59% of Bio Rad's investor base is looking to short. The analysis of overall sentiment of trading Bio Rad Laboratories stock suggests that many investors are alarmed at this time. Bio Rad's investing sentiment overview a quick insight into current market opportunities from investing in Bio Rad Laboratories. Many technical investors use Bio Rad Laboratories stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Benchmark Electronics Officer Evp, Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Read at macroaxis.com
Disposition of 3219 common stock at 29.73 of Benchmark Electronics by Roop Lakkaraju on 16th of March 2024. This event was filed by Benchmark Electronics with SEC on 2024-02-23. Statement of changes in beneficial ownership - SEC Form 4. Roop Lakkaraju currently serves as chief financial officer, executive vice president of Benchmark Electronics

Cash Flow Correlation

Bio Rad's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Bio Rad's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Bio Rad Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Bio Rad can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Bio Rad Laboratories Historical Investor Sentiment

Investor biases related to Bio Rad's public news can be used to forecast risks associated with an investment in Bio. The trend in average sentiment can be used to explain how an investor holding Bio can time the market purely based on public headlines and social activities around Bio Rad Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bio Rad's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bio Rad and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Bio Rad news discussions. The higher the estimate score, the more favorable the investor's outlook on Bio Rad.

Bio Rad Fundamental Analysis

We analyze Bio Rad's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Rad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Rad based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Insiders

Shares Owned By Insiders Comparative Analysis

Bio Rad is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Bio Rad Laboratories Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bio Rad stock to make a market-neutral strategy. Peer analysis of Bio Rad could also be used in its relative valuation, which is a method of valuing Bio Rad by comparing valuation metrics with similar companies.

Peers

Bio Rad Related Equities

ANIKAnika Therapeutics   3.02   
0%
100.0%
NVCRNovocure   1.78   
0%
58.0%
NARIInari Medical   1.74   
0%
57.0%
CNMDCONMED   1.20   
0%
39.0%
STESTERIS Plc   0.73   
0%
24.0%
GKOSGlaukos Corp   0.67   
0%
22.0%
GMEDGlobus Medical   0.38   
0%
12.0%
ZBHZimmer Biomet   0.07   
0%
2.0%
PENPenumbra   0.01   
1.0%
0%
PODDInsulet   0.05   
1.0%
0%
DXCMDexCom   0.14   
4.0%
0%
ITGRInteger Holdings   0.21   
6.0%
0%
INSPInspire Medical   0.64   
21.0%
0%
BRKRBruker   0.74   
24.0%
0%
TNDMTandem Diabetes   1.89   
62.0%
0%
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.412
Earnings Share
(28.09)
Revenue Per Share
90.815
Quarterly Revenue Growth
0.028
Return On Assets
0.0186
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.